Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis

EGPA Mepolizumab Study Team

Research output: Contribution to journalArticlepeer-review

292 Scopus citations

Fingerprint

Dive into the research topics of 'Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis'. Together they form a unique fingerprint.

Medicine & Life Sciences